What is the treatment for Steven Johnson syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Stevens-Johnson Syndrome (SJS)

The most critical first step in treating Stevens-Johnson Syndrome is immediate discontinuation of any potential culprit drug, followed by transfer to a specialized care center with experience managing SJS/TEN, preferably a burn unit or ICU for patients with >10% body surface area epidermal detachment. 1, 2

Initial Management

  • Assess severity using SCORTEN to predict mortality risk 2
  • Transfer to a specialized care center with experience managing SJS/TEN, preferably a burn unit or ICU for patients with >10% body surface area epidermal detachment 1, 2
  • Barrier nursing in a temperature-controlled room (25-28°C) on a pressure-relieving mattress 2
  • Careful fluid resuscitation to prevent end-organ hypoperfusion while avoiding fluid overload 2

Supportive Care

Wound Management

  • Minimize shearing forces when handling skin to prevent further epidermal detachment 2
  • Apply bland emollients frequently to support barrier function and reduce water loss 2
  • Leave detached epidermis in situ to act as a biological dressing 2
  • Apply nonadherent dressings to denuded dermis with secondary foam or burn dressings 2
  • Consider silver-containing products/dressings for sloughy areas only 2, 3

Infection Prevention

  • Monitor for signs of infection rather than using prophylactic antibiotics 2
  • Regular skin swabs for culture to detect predominant organisms 2
  • Targeted antimicrobial therapy only when clinical signs of infection are present 2

Mucosal Management

Ocular Care

  • Arrange ophthalmological examination within 24 hours of diagnosis with daily reviews during acute illness 1, 2
  • Apply preservative-free lubricant eye drops every two hours throughout the acute illness 2
  • Perform daily ocular hygiene to remove inflammatory debris and break down conjunctival adhesions 2
  • Administer broad-spectrum topical antibiotics when corneal fluorescein staining or ulceration is present 1, 2
  • Consider topical corticosteroids for ocular inflammation under ophthalmologist supervision 2

Oral Care

  • Daily oral review during the acute illness 1
  • Apply white soft paraffin ointment to the lips every 2 hours 1
  • Clean the mouth daily with warm saline mouthwashes or an oral sponge 1
  • Use an anti-inflammatory oral rinse containing benzydamine hydrochloride every 3 hours, particularly before eating 1
  • Use an antiseptic oral rinse containing chlorhexidine twice daily 1
  • Use a potent topical corticosteroid mouthwash (e.g., betamethasone sodium phosphate) four times daily 1
  • Consider topical anesthetics such as viscous lidocaine 2% for severe oral discomfort 1

Urogenital Care

  • Daily urogenital review during the acute illness 1
  • Apply white soft paraffin ointment to the urogenital skin and mucosae every 4 hours 1
  • Use a potent topical corticosteroid ointment once daily to involved, noneroded surfaces 1
  • Use silicone dressings (e.g., Mepitel) to eroded areas 1
  • Consider vaginal dilators or tampons wrapped in Mepitel to prevent vaginal synechiae formation 1
  • Catheterize patients to prevent urethral strictures 1

Systemic Therapy Options

  • Ciclosporin (3 mg/kg daily for 10 days, tapered over 1 month) has shown benefit with reduced mortality compared to predicted rates 2
  • Systemic corticosteroids, particularly early methylprednisolone pulse therapy, may be beneficial if started within 72 hours of onset 2, 4
  • Intravenous immunoglobulin (IVIG) has been used with some success in certain centers 5

Airway Management

  • Respiratory symptoms and hypoxemia on admission should prompt early discussion with an intensivist and rapid transfer to an ICU or burn center 1
  • Fibreoptic bronchoscopy should be undertaken to assess airway involvement 1

Discharge and Follow-up

  • Provide written information about drug(s) to avoid 1, 2
  • Encourage the patient to wear a MedicAlert bracelet 1, 2
  • Document drug allergy in the patient's notes; inform all doctors involved in the patient's care 1, 2
  • Report the episode to national pharmacovigilance authorities 1, 2
  • Organize a dermatology outpatient clinic appointment, and if required, an ophthalmology outpatient appointment, within a few weeks of discharge 1

Common Pitfalls to Avoid

  • Delayed recognition and discontinuation of the culprit medication significantly increases mortality risk 2, 4
  • Indiscriminate use of prophylactic antibiotics may increase skin colonization with resistant organisms 2
  • Overaggressive fluid resuscitation can lead to pulmonary, cutaneous, and intestinal edema 2
  • Failure to involve appropriate specialists early, particularly ophthalmology, can lead to permanent sequelae 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Stevens-Johnson Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Clinical reviews in allergy & immunology, 2018

Research

Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.

Burns : journal of the International Society for Burn Injuries, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.